Systematic phenotype and genotype characterization of Moebius syndrome
- PMID: 40662098
- PMCID: PMC12256340
- DOI: 10.1016/j.gimo.2025.103437
Systematic phenotype and genotype characterization of Moebius syndrome
Abstract
Purpose: To explore the phenotypic spectrum and genetic etiologies of Moebius Syndrome (MBS), a rare neurological disorder defined by congenital, nonprogressive facial weakness and limitations in ocular abduction.
Methods: We applied strict diagnostic criteria and conducted clinical phenotyping of 149 individuals with MBS. Subsequently, we performed exome and/or genome sequencing on 67 of these individuals and 117 unaffected family members.
Results: All 149 individuals had sporadic MBS, with no recurrence within or across generations. Common co-occurring phenotypes included tongue hypoplasia (81.9%), micrognathia (66.4%), congenital talipes equinovarus (42.3%), major limb anomalies (31.5%), intellectual disability (30.9%), sleep difficulties (22.8%), and Poland anomaly (14.1%). Filtering for rare de novo or autosomal recessive single-nucleotide, insertion/deletion, and structural variants in the sequenced cohort yielded 173 single-nucleotide variant/indels in 113 genes. Although we prioritized 7 candidate genes with de novo variants and 5 with biallelic variants, no compelling recurrently mutated genes were identified. Similarly, we found no convincing variants in 2 putative genes previously implicated in MBS: PLXND1 (HGNC:9107) and REV3L (HGNC:9968).
Conclusion: We did not identify a strong or unifying germline genetic etiology for MBS. Future studies may explore alternative causes, including environmental exposures, somatic variants, and/or complex inheritance patterns affecting brainstem and organ embryogenesis.
Keywords: Congenital facial weakness; Cranial nerve; Exome sequencing; Genome sequencing; Moebius syndrome.
Conflict of interest statement
Silvio Alessandro Di Gioia is currently an employee and stockholder of Regeneron Pharmaceutical. Ke Hao received compensation as a part time employee of GeneDx LLC and is a stockholder with the company. Flavia M. Facio is currently an employee and stockholder of Invitae Corp. Sherin Shaaban is currently an employee of ARUP Laboratories. All other authors declare no conflicts of interest.
Figures




References
-
- Moebius P.J. Ueber angeborene doppelseitige Abducens-Facialis-Laehmung. Münch Med Wochenschr. 1888;35:91–94 and 108-111.
LinkOut - more resources
Full Text Sources
Miscellaneous